Clinical trial
Physiologic Growth Hormone Effects in HIV Lipodystrophy
NCT00100698 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00100698 |
|---|---|
| Title | Physiologic Growth Hormone Effects in HIV Lipodystrophy |
| Official title | Physiologic Growth Hormone Effects in HIV Lipodystrophy |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | AIDS, HIV Infections |
| Intervention type | Drug |
| Interventions | recombinant human growth hormone, placebo |
| Enrollment | 56 |
| Start date | Jan 1, 2004 |
| Primary completion | Oct 1, 2007 |
| Completion | Apr 1, 2009 |
| First posted | Jan 5, 2005 |
| Last update posted | Jul 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: